Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

David Schultz

Tracked across 2 events · 18 articles · First seen Jun 02, 2026 · Last active Aug 15, 2026

Sentiment
40
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 60
Tech
A small but growing body of research indicates that GLP-1 drugs, commonly used for obesity and diabetes, may also be effective in treating polyendocrine metabolic ovarian syndrome (PMOS), a hormonal disorder affecting 1 in 8…
Impact: Mother of Charlotte Touzalin, also has PMOS, advocates for her daughter's treatment and is fighting with her insurer to continue GLP-1 coverage.
Aug 15, 2026 · 12 articles
2 20
Tech
Impact: David Schultz, Risk Manager for the University of Lethbridge, provided a testimonial highlighting the need for such a solution in municipal security.
Jun 02, 2026 · 6 articles
ERGEN INTELLIGENCE
Track David Schultz live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.